跳至主要内容
临床试验/DRKS00034395
DRKS00034395招募中不适用

Study of clonal hematopoiesis of undetermined potential (CHIP) and proinflammatory biomarkers in patients with early in-stent occlusion after recanalization

niversitätsklinikum Augsburg0 个研究点目标入组 25 人开始时间: 2024年6月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Competent patients who have been informed about the study both in writing and orally and have agreed to participate.
  • Women and men with PAOD stages IIb-IV who are undergoing either a first intervention with stent placement or a reintervention for stent occlusion.
  • Evidence of high-grade peripheral arterial stenoses demonstrated by duplex ultrasound (FKDS), CT, or MRI.

排除标准

  • Patients with a tumor diagnosis
  • Patients with a known coagulation disorder
  • Patients under guardianship
  • Patients with a contraindication to the recommended antiplatelet therapy
  • Patients who have prematurely discontinued or paused the recommended antiplatelet therapy

研究者

发起方
niversitätsklinikum Augsburg

相似试验

Study of clonal hematopoiesis of undetermined... | 临床试验